Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

New Data, Same Story: Disease Still Concentrated in Middle-Income Countries

This is a joint post with Yuna Sakuma.

The majority of the world’s sick live in middle-income countries (MIC) – mainly Pakistan, India, Nigeria, China and Indonesia (or PINCI), according to new data from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.  Sound familiar? Andy Sumner, Denizhan Duran, and I came to the same conclusion in a 2011 paper, but we used 2004 disease burden data, which didn’t provide an up-to-date view of reality.  So I was pleased to see that our findings still hold based on IHME’s 2010 Global Burden of Disease (GBD) estimates.  

Is the Price Right? Evaluating Advanced Market Commitments for Vaccines

CGD has been following Advanced Market Commitment (AMC) for vaccines for a while now: from its groundwork in the CGD report Making Markets for Vaccines, to its launch and the delivery of its first vaccines in 2010 (GAVI also offers a nice timeline of events here).  This innovative financing mechanism aims to increase investment in vaccines for use in lower-middle income countries (LMIC)by guaranteeing a market for appropriate health products and services, reducing unpredictability or volatility that can discourage private investment, and increasing competition and innovation between companies and organizations (read more here).